Clinical Trials
3 trialsNCT06789172 2026-05-22
INVOKE
Epkin
Phase 1 Recruiting
NCT04840615 2024-02-02
Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT00451880 2011-10-13
Study of XL281 in Adults With Solid Tumors
Exelixis
Phase 1 Completed